Successful treatment of refractory systemic lupus erythematosus with intravenous immunoglobulins

K. Akashi, K. Nagasawa, T. Mayumi, E. Yokota, N. Oochi, T. Kusaba

研究成果: ジャーナルへの寄稿学術誌査読

24 被引用数 (Scopus)

抄録

Two cases of refractory systemic lupus erythematosus (SLE) were successfully treated with intravenous immunoglobulins (IVIg). In Case 1, the immediate recovery from severe pancytopenia and the improvement of proteinuria were observed, following IVIg therapy in high doses (450 mg/kg) for 5 consecutive days. In Case 2, 3 courses of IVIg therapy (100 mg/kg) for 6 to 8 days resulted in a significant reduction of massive proteinuria. In both cases, the improvement of immunological variables was also seen.

本文言語英語
ページ(範囲)375-379
ページ数5
ジャーナルJournal of Rheumatology
17
3
出版ステータス出版済み - 1月 1 1990

!!!All Science Journal Classification (ASJC) codes

  • リウマチ学
  • 免疫アレルギー学
  • 免疫学

フィンガープリント

「Successful treatment of refractory systemic lupus erythematosus with intravenous immunoglobulins」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル